OFFICIAL PUBLICATION OF

by its subsidiary APPco

Recognise supply chain blood and cuts

Guest Author 23/10/2016

How price cuts impact the supply chain, by Bruce Annabel and Mal Scrymgeour The 1 October price cuts were a much less bloody affair than many had imagined. The reasons we ended up experiencing relatively less pain appear to be: Crestor stayed in the Rosuvastatin WADP calculation, because it hadn’t been in the price disclosure

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Recognise supply chain blood and cuts

Previous Poll: why do you want to vaccinate?

Next Profession split on GP dispensing

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Poll: why do you want to vaccinate?

Next Profession split on GP dispensing

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.